ALDH1A1 in patient‐derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression-Reference-Cited by-同舟云学术

ALDH1A1 in patient‐derived bladder cancer spheroids activates retinoic acid signaling leading to TUBB3 overexpression and tumor progression

Published:2019-06-24 Issue:4 Volume:146 Page:1099-1113
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Namekawa Takeshi¹²,Ikeda Kazuhiro¹,Horie‐Inoue Kuniko¹,Suzuki Takashi³,Okamoto Koji⁴,Ichikawa Tomohiko²,Yano Akihiro⁵,Kawakami Satoru⁵,Inoue Satoshi¹⁶^ORCID

Affiliation:

1. Division of Gene Regulation and Signal Transduction, Research Center for Genomic MedicineSaitama Medical University Hidaka Japan

2. Department of UrologyGraduate School of Medicine, Chiba University Chiba Japan

3. Department of Pathology and HistotechnologyTohoku University Graduate School of Medicine Sendai Japan

4. Division of Cancer DifferentiationNational Cancer Center Hospital Tokyo Japan

5. Department of Urology, Saitama Medical CenterSaitama Medical University Kawagoe Japan

6. Department of Functional BiogerontologyTokyo Metropolitan Institute of Gerontology Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Japan Society for the Promotion of Science

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.32505

Reference53 articles.

1. Global cancer statistics, 2012

2. Bladder cancer

3. The cancer stem cell: premises, promises and challenges

4. Therapeutic Approaches to Target Cancer Stem Cells

5. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinoma;Gynecologic Oncology;2024-07

2. Targeted therapies in bladder cancer: signaling pathways, applications, and challenges;MedComm;2023-12

3. Modification of lysine-260 2-hydroxyisobutyrylation destabilizes ALDH1A1 expression to regulate bladder cancer progression;iScience;2023-11

4. Clinicopathological significance of TUBB3 in upper tract urothelial carcinoma and possible application in urine cytology;Pathology International;2023-08-17

5. Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers;Frontiers in Cell and Developmental Biology;2023-08-11